Category: New products
-
Precision Cancer Meds Company Raises $43M in Early Funds
A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round.
-
Medical Centers Join Covid-19 Digital Biomarker Trial
Three more medical centers are taking part in a clinical trial testing a mobile early-warning system that monitors Covid-19 patients with wearable sensors.
-
Infographic – Americans Support Sending Vaccines Abroad
About two in three Americans are in favor of the U.S. sending Covid-19 vaccine doses to other countries where infections remain a problem.
-
Trial Underway Testing Cannabis Migraine Treatments
A clinical trial is enrolling participants to test three different types of inhaled cannabis therapies against a placebo to treat migraine.
-
Crispr Treatment Leads to Durable Cholesterol Reduction
A developer of gene editing for inherited heart disease reports lab monkeys given its therapy experience lower cholesterol levels for at least eight months.
-
Small Biz Grant Funds Covid-19 Antiviral Therapy
A biotechnology company developing cancer therapies is receiving an NIH grant to extend its technology for antiviral peptides against the SARS-CoV-2 virus.
-
Gene Therapy Company Starts-Up, Gains $200M
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million.
-
Medical Devices to Reduce Military Travel Disorders
Biomedical engineers at university labs are designing medical devices that reduce jet lag and intestinal problems faced by military service members.
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.